HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Interpretive Summary Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pol, M. Articles by Ruegg, P. L. Search for Related Content PubMed PubMed Citation Articles by Pol, M. Articles by Ruegg, P. L.

Relationship Between Antimicrobial Drug Usage and Antimicrobial Susceptibility of Gram-Positive Mastitis Pathogens

Department of Dairy Science, University of Wisconsin, Madison 53706

¹ Corresponding author: plruegg{at}wisc.edu

The objective of this study was to analyze relationships between usage of antimicrobial drugs on dairy farms and results of antimicrobial susceptibility testing of mastitis pathogens. Exposure to selected antimicrobial drugs (n = 10) was standardized by calculation of the number of defined daily doses used per cow. Farms (n = 40) were categorized based on amount of antimicrobial exposure: organic (no usage); conventional–low usage (conventional farms not using or using less than or equal to the first quartile of use of each compound); and conventional–high usage (conventional farms using more than the first quartile of a particular compound). The minimum inhibitory concentration (MIC) of selected antimicrobial drugs was determined using a commercial microbroth dilution system for isolates of Staphylococcus aureus (n = 137), coagulase-negative staphylococci (CNS, n = 294), and Streptococcus spp. (n = 95) obtained from subclinical mastitis infections. Most isolates were inhibited at the lowest dilution tested of most antimicrobial drugs. Survival curves for Staph. aureus and CNS demonstrated heterogeneity in MIC based on the amount of exposure to penicillin and pirlimycin. For CNS, farm type was associated with the MIC of ampicillin and tetracycline. For Streptococcus spp., farm type was associated with MIC of pirlimycin and tetracycline. For all mastitis pathogens studied, the MIC of pirlimycin increased with increasing exposure to defined daily doses of pirlimycin. The level of exposure to most other antimicrobial drugs was not associated with MIC of mastitis pathogens. A dose–response effect between antimicrobial exposure and susceptibility was observed for some pathogen–antimicrobial combinations, but exposure to other antimicrobial drugs commonly used for prevention and treatment of mastitis was not associated with resistance.

Key Words: dairy • resistance • antibiotic • mastitis

This article has been cited by other articles:

				A. Pitkala, J. Koort, and J. Bjorkroth Identification and Antimicrobial Resistance of Streptococcus uberis and Streptococcus parauberis Isolated from Bovine Milk Samples J Dairy Sci, October 1, 2008; 91(10): 4075 - 4081. [Abstract] [Full Text] [PDF]

				M. Pol and P. L. Ruegg Treatment Practices and Quantification of Antimicrobial Drug Usage in Conventional and Organic Dairy Farms in Wisconsin J Dairy Sci, January 1, 2007; 90(1): 249 - 261. [Abstract] [Full Text] [PDF]